You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 204439_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 310166_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 378860_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 433209_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 450006_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

Last updated: August 20, 2025


Introduction

Sodium chloride 5% solution, commonly known as saline, is a vital component in medical settings, primarily used for intravenous (IV) therapy, wound irrigation, and as a diluent for medications. The increasing demand for sterile, high-quality APIs has intensified sourcing considerations for pharmaceutical manufacturers. This article offers a comprehensive review of bulk API sources for Sodium Chloride 5% in plastic containers, analyzing key manufacturers, market dynamics, regulatory standards, and supply chain factors critical to procurement decisions.


Market Overview and Demand Dynamics

The global saline solution market is projected to grow driven by ongoing needs in hospitals, clinics, and outpatient settings. The World Health Organization estimates that saline solutions constitute over 50% of IV fluids used globally. Amidst rising healthcare infrastructure, especially in emerging economies, consistent supply of high-quality Sodium Chloride 5% API is paramount.

The API for Sodium Chloride used in sterile, injectable formulations must comply with strict pharmacopeial standards—for example, the United States Pharmacopeia (USP), European Pharmacopoeia (EP), or the Japanese Pharmacopoeia (JP). The API manufacturing process emphasizes purity, sterility, and low endotoxin levels, critical for safety and regulatory approval.


Major API Suppliers for Sodium Chloride 5% Solution

1. Global API Manufacturers

Most API manufacturing exists within a well-established global network of pharmaceutical-grade chemical providers. Key players include:

  • Bhageria Industries Ltd. (India)
    A prominent manufacturer offering pharmaceutical-grade Sodium Chloride APIs suitable for injectable solutions. The company adheres to GMP standards, with products compliant with USP and EP pharmacopeia requirements. Bhageria supplies in bulk quantities, including suitable packaging for pharmaceutical use.

  • G-Chem Industries Ltd. (India)
    This Indian-based API producer supplies Sodium Chloride APIs aligned with international quality standards. Their facilities maintain ISO and cGMP certifications, ensuring compliance with regulatory norms and high purity levels.

  • FMC Corporation (USA)
    FMC produces high-purity Sodium Chloride APIs for injectable use, emphasizing quality control and consistent supply. Their products meet global pharmacopeial standards and are widely used in sterile saline production.

  • Qingdao Hanrui Pharmaceutical Co., Ltd. (China)
    A major Chinese API supplier with extensive manufacturing facilities certified by GMP. Their Sodium Chloride APIs are extensively exported and considered reliable sources for pharmaceutical-grade raw materials.

  • Shandong Xinhua Pharmaceutical Co., Ltd. (China)
    This company supplies pharmaceutical-grade Sodium Chloride APIs with certifications aligning with pharmacopeial standards, supporting global sterile solution manufacturing.

2. Specialized Saline API Manufacturers

Certain companies focus exclusively on producing high-purity saline APIs suitable for sterile injections:

  • VIVA Pharmaceutical (India)
    Known for pharmaceutical excipients and APIs, VIVA supplies Sodium Chloride APIs, emphasizing compliance with USP, EP, and JP standards for injectable-grade saline.

  • Siegfried Holding AG (Switzerland)
    With their robust manufacturing process, Siegfried offers high-quality APIs for injectable solutions, ensuring strict endotoxin control and sterility compatibility.

3. Regional Suppliers and Distributors

Regional API suppliers often serve local markets with competitive pricing and flexible delivery options:

  • Sri Lanka’s Jayasanka Chemicals
    Offers pharmaceutical-grade NaCl APIs suitable for saline solutions, with compliance to international standards.

  • Local Distributors in Europe and North America
    Many firms act as intermediaries, sourcing APIs from major manufacturers and ensuring regulatory compliance, thus facilitating easier procurement for regional manufacturers.


Criteria for Selecting API Suppliers

Selection hinges on multiple factors, including:

  • Regulatory Compliance
    Suppliers must hold certifications like GMP, ISO 9001, and provide documentation validating adherence to USP, EP, or JP standards.

  • Purity and Sterility
    The API must exhibit pharmaceutical-grade purity, low endotoxin levels, and be suitable for sterile injection manufacturing.

  • Quality Control and Testing
    Reliable testing protocols, including microbial endotoxin testing, residual moisture, and heavy metal analysis, must be in place.

  • Supply Chain Reliability
    Consistent delivery schedules, inventory management, and contingency options are vital to avoid production disruptions.

  • Pricing and Terms
    Competitive pricing coupled with flexible payment and delivery terms influence supplier decisions.


Regulatory and Quality Standards in API Procurement

API manufacturers and purchasers must comply with evolving global standards:

  • Pharmacopoeial Compliance: Ensuring APIs conform to the latest USP, EP, or JP standards for sodium chloride in injectable forms.

  • Pharmaceutical Quality System (PQS): Manufacturers must maintain rigorous QA/QC systems, with audits regularly conducted by customers or regulatory authorities.

  • Sterility and Endotoxin Testing: To qualify for injectable applications, APIs undergo bacterial endotoxin testing (BET), sterility confirmation, and pyrogen assessments.

  • Documentation and Traceability: Certificates of Analysis (CoA), Certificate of Compliance (CoC), and batch traceability are non-negotiable.


Supply Chain Considerations

The supply chain for Sodium Chloride API faces challenges such as geopolitical tensions, raw material shortages, and manufacturing disruptions. Strategies to mitigate risks include:

  • Diversification: Source from multiple suppliers across different regions to avoid over-reliance on a single source.

  • Strategic Stockpiling: Maintain safety stocks, especially for critical markets.

  • Long-Term Contracts: Establish agreements to secure supply stability and favorable pricing.

  • Regulatory Alignment: Regularly update import/export documentation to meet changing regulatory requirements in target markets.


Emerging Trends and Innovations

The global API industry is shifting toward:

  • Sustainable Manufacturing: Minimizing environmental impact through greener processes.

  • Enhanced Quality Frameworks: Increasing emphasis on process validation and continuous quality improvement.

  • Digital Supply Chains: Leveraging technology for real-time tracking, inventory management, and predictive analytics to forecast demand.


Key Challenges and Opportunities

Challenges:

  • Maintaining high purity standards amid complex manufacturing processes.

  • Navigating regulatory harmonization across jurisdictions.

  • Ensuring supply chain resilience in light of geopolitical tensions.

Opportunities:

  • Growing demand in emerging markets with improved healthcare infrastructure.

  • Increasing adoption of sterile saline in diverse medical applications.

  • Potential for strategic partnerships with OEMs and private label manufacturers.


Conclusion

Securing a reliable source of bulk Sodium Chloride 5% API in plastic containers involves evaluating multiple factors: regulatory compliance, purity, supply reliability, and cost. Major global manufacturers like Bhageria Industries, FMC, Qingdao Hanrui Pharmaceutical, and Siegfried Holding offer high-quality APIs compliant with international standards. Regional suppliers provide additional flexibility but require stringent qualification processes. Maintaining quality assurance, fostering supplier relationships, and monitoring regulatory developments underpin successful procurement strategies in this critical healthcare segment.


Key Takeaways

  • Diverse Supplier Base: Leverage global and regional manufacturers to optimize supply stability.

  • Rigorous Qualification: Ensure suppliers meet GMP, ISO certifications, and pharmacopeial standards.

  • Supply Chain Resilience: Implement risk mitigation strategies to counter disruptions.

  • Regulatory Vigilance: Stay updated on evolving standards to maintain compliance and market access.

  • Innovation and Sustainability: Embrace emerging manufacturing technologies and environmentally conscious practices to future-proof supply chains.


FAQs

1. What are the primary quality standards for Sodium Chloride API used in injectable solutions?
The API must comply with pharmacopeial standards such as USP, EP, or JP, which specify purity, sterility, endotoxin levels, and physical characteristics suitable for IV use.

2. How can a pharmaceutical company verify the quality of Sodium Chloride API?
Verification involves reviewing Certificates of Analysis, conducting in-house or third-party testing for microbial limits, endotoxins, heavy metals, and sterility, in addition to supplier audits.

3. What are common risks associated with sourcing Sodium Chloride API globally?
Risks include regulatory non-compliance, supply chain interruptions, quality variability, geopolitical conflicts, and raw material shortages.

4. How do geopolitical factors influence API sourcing strategies?
Trade restrictions, tariffs, and regional political stability can impact sourcing decisions, prompting diversification and local sourcing initiatives.

5. What trends are shaping the future of Sodium Chloride API supply?
Emphasis on sustainable manufacturing, digital tracking systems, enhanced quality frameworks, and strategic partnerships are key trends shaping the industry.


References

[1] World Health Organization. "The Use of Saline Solutions in Healthcare." WHO Reports, 2022.
[2] United States Pharmacopeia. "USP Monograph on Sodium Chloride." USP, 2023.
[3] European Pharmacopoeia. "Monograph on Sodium Chloride," EDQM, 2023.
[4] Industry Reports. "Global Saline Solution Market Analysis," Pharma Industry Insights, 2022.
[5] API Manufacturer Websites and Certification Pages.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.